Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Ofman J.J.,,The economic impact of the diagnosis of dysplasia in Barrett's esophagus,2000,American Journal of Gastroenterology,28,10.1016/S0002-9270(00)02002-5,United States,Article,Beverly Hills,0,Journal,2-s2.0-0033784968
Reid B.,,Predictors of progression to cancer in Barrett's esophagus: Baseline histology and flow cytometry identify low- and high-risk patient subsets,2000,American Journal of Gastroenterology,570,10.1016/S0002-9270(00)00988-6,United States;United States,Article,Seattle;Seattle,0,Journal,2-s2.0-0033915683
van Sandick J.,,Computerized quantitative pathology for the grading of dysplasia in surveillance biopsies of Barrett's oesophagus,2000,Journal of Pathology,43,10.1002/(SICI)1096-9896(200002)190:2<177::AID-PATH508>3.0.CO;2-X,Netherlands,Article,Amsterdam,0,Journal,2-s2.0-0033952888
Pera M.,,"Epidemiology of esophageal cancer, especially adenocarcinoma of the esophagus and esophagogastric junction.",2000,Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer,78,10.1007/978-3-642-59600-1_1,Spain,Review,Barcelona,0,Journal,2-s2.0-0033630558
Prevo L.J.,,p53-mutant clones and field effects in Barrett's esophagus,1999,Cancer Research,160,,United States,Article,Seattle,0,Journal,2-s2.0-0033214611
Barry O'Connor J.,,The incidence of adenocarcinoma and dysplasia in Barrett's esophagus report on the Cleveland Clinic Barrett's esophagus registry,1999,American Journal of Gastroenterology,343,10.1016/S0002-9270(99)00331-7,United States,Article,Cleveland,0,Journal,2-s2.0-0033180027
Provenzale D.,,Barrett's esophagus: A new look at surveillance based on emerging estimates of cancer risk,1999,American Journal of Gastroenterology,322,10.1111/j.1572-0241.1999.01276.x,United States,Article,Durham,0,Journal,2-s2.0-0033180014
Barrett M.,,Evolution of neoplastic cell lineages in Barrett oesophagus,1999,Nature Genetics,365,10.1038/8816,United States,Article,Stanford,0,Journal,2-s2.0-0032953491
Alikhan M.,,Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice,1999,Gastrointestinal Endoscopy,153,10.1016/S0016-5107(99)70339-1,United States,Article,Indianapolis,0,Journal,2-s2.0-0033042835
Ouatu-Lascar R.,,Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression,1999,Gastroenterology,332,10.1053/gast.1999.0029900327,United States,Article,Palo Alto,0,Journal,2-s2.0-0032782622
Polkowski W.,,Clinical decision making in Barrett's oesophagus can be supported by computerized immunoquantitation and morphometry of features associated with proliferation and differentiation,1998,Journal of Pathology,41,10.1002/(SICI)1096-9896(199802)184:2<161::AID-PATH971>3.0.CO;2-2,Poland,Article,Lublin,0,Journal,2-s2.0-0031885831
Gleeson C.,,Comparison of p53 and DNA content abnormalities in adenocarcinoma of the oesophagus and gastric cardia,1998,British Journal of Cancer,80,10.1038/bjc.1998.44,United Kingdom,Article,Belfast,1,Journal,2-s2.0-0031985694
Lanni J.,,Characterization of the p53-dependent postmitotic checkpoint following spindle disruption,1998,Molecular and Cellular Biology,432,10.1128/MCB.18.2.1055,United States,Article,Cambridge,1,Journal,2-s2.0-0031931414
O'Connor P.,,"Mammalian G<inf>1</inf>, and G<inf>2</inf> Phase Checkpoints",1997,Cancer Surveys,185,,United States,Article,Bethesda,0,Journal,2-s2.0-0030612166
Cameron A.,,Barrett's esophagus: Does the incidence of adenocarcinoma matter?,1997,American Journal of Gastroenterology,41,,United States,Editorial,Rochester,0,Journal,2-s2.0-0031045899
Drewitz D.,,The incidence of adenocarcinoma in Barrett's esophagus: A prospective study of 170 patients followed 4.8 years,1997,American Journal of Gastroenterology,478,,United States,Article,Tucson,0,Journal,2-s2.0-0031039244
Grimm I.,,Surveillance for Barrett's esophagus: are we saving lives?,1997,Gastroenterology,8,10.1053/gast.1997.v112.agast970661,,Article,,0,Journal,2-s2.0-0031065175
Andreassen P.,,Chemical induction of mitotic checkpoint override in mammalian cells results in aneuploidy following a transient tetraploid state,1996,Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis,88,10.1016/S0027-5107(96)00138-8,France,Conference Paper,Grenoble,0,Journal,2-s2.0-0030451851
Galipeau P.,,"17p (p53) allelic losses, 4N (G<inf>2</inf>/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus",1996,Proceedings of the National Academy of Sciences of the United States of America,254,10.1073/pnas.93.14.7081,United States,Article,Seattle,1,Journal,2-s2.0-0030013170
Farrow D.,,Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States),1996,Cancer Causes and Control,129,10.1007/BF00052937,United States;United States,Article,Seattle;Seattle,0,Journal,2-s2.0-0029978656
Van Der Burgh A.,,Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus,1996,Gut,291,10.1136/gut.39.1.5,Netherlands,Article,Rotterdam,1,Journal,2-s2.0-0029980994
Cross S.,,A p53-dependent mouse spindle checkpoint,1995,Science,661,10.1126/science.7871434,United States,Article,Seattle,0,Journal,2-s2.0-0028913739
Spechler S.,,Prevalence of metaplasia at the gastro-oesophageal junction,1994,The Lancet,514,10.1016/S0140-6736(94)90349-2,United States,Article,Boston,0,Journal,2-s2.0-0028036837
Giaretti W.,,A model of DNA aneuploidization and evolution in colorectal cancer,1994,Laboratory Investigation,94,,Italy,Article,Genova,0,Journal,2-s2.0-0028609054
Sagan C.,,Observer variation in the diagnosis of dysplasia in Barrett's mucosa,1994,Gastroenterologie Clinique et Biologique,35,,France,Conference Paper,Nantes,0,Journal,2-s2.0-0028316690
Rusch V.W.,,The management of high grade dysplasia and early cancer in Barrett's esophagus,1994,Cancer,65,10.1002/1097-0142(19940815)74:4<1225::AID-CNCR2820740408>3.0.CO;2-Q,United States,Article,New York,1,Journal,2-s2.0-0027977997
Hamelin R.,,TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus,1994,Gastroenterology,159,10.1016/0016-5085(94)90225-9,France,Article,Paris,0,Journal,2-s2.0-0028027356
Peters J.H.,,Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients,1994,Journal of Thoracic and Cardiovascular Surgery,369,10.1016/S0022-5223(94)70178-4,United States,Article,Los Angeles,1,Journal,2-s2.0-0028027451
Blot W.,,Continuing Climb in Rates of Esophageal Adenocarcinoma: An Update,1993,JAMA: The Journal of the American Medical Association,369,10.1001/jama.1993.03510110056031,United States,Letter,Bethesda,0,Journal,2-s2.0-0027227657
Wheeless L.,,Consensus review of the clinical utility of dna cytometry in bladder cancer,1993,Cytometry,107,10.1002/cyto.990140504,United States,Article,Rochester,0,Journal,2-s2.0-0027288071
Hedley D.,,Consensus review of the clinical utility of dna cytometry in carcinoma of the breast,1993,Cytometry,189,10.1002/cyto.990140505,Canada,Article,Toronto,1,Journal,2-s2.0-0027217424
Shankey T.,,Guidelines for implementation of clinical DNA cytometry,1993,Cytometry,380,10.1002/cyto.990140503,United States,Article,Maywood,1,Journal,2-s2.0-0027289565
Levine D.,,An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus,1993,Gastroenterology,488,10.1016/0016-5085(93)90008-Z,United States;United States,Article,Seattle;New York,0,Journal,2-s2.0-0027302718
Wang H.,,Barrett's esophagus: The cytology of dysplasia in comparison to benign and malignant lesions,1992,Acta Cytologica,25,,United States,Article,Chicago,0,Journal,2-s2.0-0026504489
Gray M.,,Epithelial proliferation in Barrett's esophagus by proliferating cell nuclear antigen immunolocalization,1992,Gastroenterology,91,10.1016/0016-5085(92)91433-5,United Kingdom;United Kingdom;United Kingdom,Article,Liverpool;London;Dundee,0,Journal,2-s2.0-0026454961
Reid B.J.,,Flow-cytometric and histological progression to malignancy in Barrett's esophagus: Prospective endoscopic surveillance of a cohort,1992,Gastroenterology,411,10.1016/0016-5085(92)70015-4,United States,Article,Seattle,0,Journal,2-s2.0-0026518795
Blot W.,,Rising Incidence of Adenocarcinoma of the Esophagus and nGastric Cardia,1991,JAMA: The Journal of the American Medical Association,2083,10.1001/jama.1991.03460100089030,United States,Article,Bethesda,0,Journal,2-s2.0-0026028040
Robaszkiewicz M.,,Flow cytometric analysis of nuclear DNA content in Barrett's esophagus. A study of 66 cases,1991,Gastroenterologie Clinique et Biologique,21,,France,Article,Brest,0,Journal,2-s2.0-0025939965
Williamson W.,,Barrett’s Esophagus: Prevalence and Incidence of Adenocarcinoma,1991,Archives of Internal Medicine,230,10.1001/archinte.1991.00400110070014,United States,Article,Burlington,0,Journal,2-s2.0-0025724070
Miros M.,,Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus,1991,Gut,272,10.1136/gut.32.12.1441,Australia,Article,Woolloongabba,1,Journal,2-s2.0-0025791931
Ovaska J.,,Adenocarcinoma arising in Barrett's esophagus,1989,Digestive Diseases and Sciences,99,10.1007/BF01538065,Finland,Article,Helsinki,0,Journal,2-s2.0-0024450023
Burholt D.R.,,Karyotypic Evolution of a Human Undifferentiated Large Cell Carcinoma of the Lung in Tissue Culture,1989,Cancer Research,25,,United States,Article,Pittsburgh,0,Journal,2-s2.0-0024397150
Shackney S.E.,,Model for the Genetic Evolution of Human Solid Tumors,1989,Cancer Research,232,,United States,Article,Pittsburgh,0,Journal,2-s2.0-0024406882
Blomjous E.,,The value of morphometry and DNA flow cytometry in addition to classic prognosticators in superficial urinary bladder carcinoma,1989,American Journal of Clinical Pathology,68,10.1093/ajcp/91.3.243,Netherlands,Article,Amsterdam,0,Journal,2-s2.0-0024592258
Alanen K.,,Autolysis is a potential source of false aneuploid peaks in flow cytometric DNA histograms,1989,Cytometry,83,10.1002/cyto.990100409,Finland,Article,Abo,0,Journal,2-s2.0-0024411208
Rabinovitch P.,,Progression to cancer in Barrett's esophagus is associated with genomic instability,1989,Laboratory Investigation,181,,United States,Article,Seattle,0,Journal,2-s2.0-0024502671
Hameeteman W.,,Barrett's Esophagus; Development of Dysplasia and Adenocarcinoma,1989,Gastroenterology,823,10.1016/S0016-5085(89)80011-3,Netherlands,Article,Amsterdam,0,Journal,2-s2.0-0024505079
DeVere White R.W.,,The predictive value of flow cytometric information in the clinical management of stage O (Ta) bladder cancer,1988,Journal of Urology,50,10.1016/S0022-5347(17)42386-X,United States,Article,Sacramento,0,Journal,2-s2.0-0002650783
Achkar E.,,The Cost of Surveillance for Adenocarcinoma Complicating Barrett's Esophagus,1988,The American Journal of Gastroenterology,117,10.1111/j.1572-0241.1988.tb02347.x,United States,Article,Cleveland,0,Journal,2-s2.0-0023894922
Robertson C.S.,,Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus,1988,British Journal of Surgery,260,10.1002/bjs.1800750813,United Kingdom,Article,Nottingham,0,Journal,2-s2.0-0023686651
Reid B.,,Observer variation in the diagnosis of dysplasia in Barrett's esophagus,1988,Human Pathology,652,10.1016/S0046-8177(88)80344-7,,Article,,0,Journal,2-s2.0-0023906902
Barlogie B.,,Characterization of hematologic malignancies by flow cytometry,1987,Analytical and Quantitative Cytology and Histology,12,,United States,Review,Houston,0,Journal,2-s2.0-0023189495
Ornitz D.,,Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice,1987,Science,179,10.1126/science.2821617,United States,Article,Seattle,0,Journal,2-s2.0-0023247255
Reid B.,,Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma,1987,Gastroenterology,239,10.1016/0016-5085(87)90306-4,United States,Article,Seattle,0,Journal,2-s2.0-0023236047
Spechler S.,,Barrett's Esophagus,1986,New England Journal of Medicine,708,10.1056/NEJM198608073150605,United States,Review,Boston,0,Journal,2-s2.0-0022469276
Le Beau M.M.,,Chromosomal abnormalities in leukemia and lymphoma: clinical and biological significance.,1986,Advances in human genetics,55,10.1007/978-1-4615-8356-1_1,,Review,,0,Journal,2-s2.0-0022588396
Metz C.E.,,Special articles roc methodology in radiologic imaging,1986,Investigative Radiology,1464,10.1097/00004424-198609000-00009,United States,Article,Chicago,0,Journal,2-s2.0-0022470978
Cameron A.,,The Incidence of Adenocarcinoma in Columnar-Lined (Barrett's) Esophagus,1985,New England Journal of Medicine,669,10.1056/NEJM198510033131404,United States,Article,Rochester,0,Journal,2-s2.0-0022253063
Ewers S.,,Flow‐Cytometric DNA analysis in primary breast carcinomas and clinicopthological correlations,1984,Cytometry,194,10.1002/cyto.990050419,Sweden,Article,Lund,1,Journal,2-s2.0-0021275845
Darzynkiewicz Z.,,Accessibility of DNA in situ to various fluorochromes: Relationship to chromatin changes during erythroid differentiation of friend leukemia cells,1984,Cytometry,227,10.1002/cyto.990050411,United States,Article,New York,1,Journal,2-s2.0-0021280282
Spechler S.J.,,Adenocarcinoma and Barrett's esophagus. An overrated risk?,1984,Gastroenterology,440,10.1016/0016-5085(84)90090-8,United States;United States;United States,Article,Boston;Boston;Boston,1,Journal,2-s2.0-0021221863
Gustafson H.,,DNA profile and tumour progression in patients with superfical bladder tumours,1982,Urological Research,96,10.1007/BF00256518,Sweden,Article,Stockholm,0,Journal,2-s2.0-0020079306
Pellish L.,,Cell proliferation in three types of Barrett's epithelium,1980,Gut,54,10.1136/gut.21.1.26,United States,Article,,1,Journal,2-s2.0-0018844287
Herbst J.J.,,Cell proliferation in esophageal columnar epithelium (Barrett's esophagus),1978,Gastroenterology,79,10.1016/s0016-5085(19)31680-4,United States,Article,Salt Lake City,1,Journal,2-s2.0-0018119911
